title: [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER].
abstract: The aim of the study was to analyze the role of the kallikrein-kinin and renin-angiotensin systems in the molecular mechanisms of prostate cancer (PCa) and use the findings for identification of new markers of the disease. Analysis of proteolytic disturbances in the prostatic secretions in benign prostatic hyperplasia (BPH) and prostate cancer based on the identification of key indicators of the kallikrein-kinin and renin-angiotensin system in the prostate secretion showed that kallikrein activity in prostate cancer is higher and the activity of angiotensin converting enzymes (ACE), by contrast, is lower than in BPH, apparently reflecting the reduction of angiotensin II and increase of the bradykinin content. A characteristic feature of prostate cancer is a dramatic increase in the inhibitory capacity of prostate secretion. It was found that in BPH patients, expression of B1 receptors in the prostate tissue is completely absent. The specific response with anti-B1 antibodies in the glandular epithelium was observed in malignant foci acini and prostatic intraepithelial neoplasia. In contrast, expression of the B2 receptors occurs in the stroma of both BPH and prostate cancer independent of stage and Gleason score. Indicators of kallikrein and ACE activity in prostate secretion and expression of the B1 receptors in prostate tissue may be utilized for prostate cancer diagnosis.
authors.forename: M I
authors.initials: MI
authors.lastname: Kogan
authors.forename: E A
authors.initials: EA
authors.lastname: Chernogubova
authors.forename: M B
authors.initials: MB
authors.lastname: Chibichjan
authors.forename: A Je
authors.initials: AJ
authors.lastname: Macionis
authors.forename: P Je
authors.initials: PJ
authors.lastname: Povilajtite
authors.forename: D G
authors.initials: DG
authors.lastname: Matishov
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D016022:Case-Control Studies; D006801:Humans; D007150:Immunohistochemistry; D016234:Kallikrein-Kinin System / Q000502:physiology*; D008297:Male; D060787:Neoplasm Grading; D011470:Prostatic Hyperplasia / Q000209:etiology* / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000209:etiology* / Q000378:metabolism*; D012084:Renin-Angiotensin System / Q000502:physiology*
chemical_list: D014408:Biomarkers, Tumor